-
Latecomer Japan eyes slice of rising global defence spending
-
Messi goal not enough as Miami collapse in 4-3 loss to Orlando
-
German fertiliser makers and farmers struggle with Iran war fallout
-
OPEC+ to make first post-UAE production decision
-
Massive crowds fill Rio's Copacabana beach for Shakira concert
-
Embiid, Maxey shine as 76ers eliminate Celtics in NBA playoffs
-
Fleeting freedom at festival for India's transgender community
-
Trump says cutting US troop numbers in Germany 'way down'
-
Man charged with murdering Indigenous girl in Australian outback
-
China's Wu Yize wins last-frame thriller to reach snooker world final
-
Serene Korda takes three-shot lead at LPGA Mexico
-
Golden Tempo wins Kentucky Derby in historic triumph for trainer DeVaux
-
King Charles grasped 'opportunity' on US trip, palace says
-
China's Wu wins last-frame thriller to reach snooker world final
-
Verstappen sees light at the end of tunnel
-
Young stretches PGA lead to six at Doral
-
Rio's Copacabana beach hosts massive crowd for free Shakira concert
-
Celtics' Tatum ruled out for decisive game seven against Sixers
-
Wolff heralds Antonelli speed as teen joins Senna and Schumacher in record books
-
Senior Iranian officer says fresh conflict with US 'likely'
-
Barcelona on verge of Liga title, Villarreal secure top four
-
Teen F1 leader Antonelli takes Miami Grand Prix pole
-
Porto edge Alverca to clinch Portuguese league title
-
US airlines step up as Spirit winds down
-
Barcelona on verge of La Liga title defence with win at Osasuna
-
Drugmaker asks US Supreme Court to restore abortion pill access
-
Schalke return to Bundesliga after three-year absence
-
NATO, top Republicans question US troop withdrawal from Germany
-
Napoli frustrate Como in costly Serie A stalemate
-
Illegal party at French military site draws up to 40,000 ravers
-
Arsenal hit stride to go six points clear, West Ham loss offers Spurs hope
-
Arsenal go six points clear as Gyokeres double sinks Fulham
-
Clinical Chennai down Mumbai to keep playoff hopes alive
-
Napoli and Como play out goalless draw in Serie A
-
Murphy into World Snooker Championship final after edging Higgins
-
PSG held by Lorient with fringe team ahead of Bayern Munich return leg
-
Aviation companies step up as Spirit winds down
-
Champion Norris leads Piastri home in sprint 1-2 triumph for McLaren
-
UK PM says some pro-Palestinian marches could be banned
-
The Puma out of Kentucky Derby, leaving 19 starters
-
'Bookless bookstore': audio-only book shop opens in New York
-
Kostyuk defeats Andreeva to claim first Madrid Open title
-
Leinster survive Toulon scare to reach Champions Cup final
-
Villarreal secure Champions League spot, rotated Atletico win
-
'Relieved' Inoue outlasts Nakatani in Tokyo Dome superfight
-
Israel quizzes two Gaza flotilla activists, angering Spain
-
West Ham defeat gives Spurs hope, Arsenal face Fulham test
-
Second-string Bayern held by Heidenheim before PSG clash
-
Lyon edge Arsenal to reach women's Champions League final
-
Struggling Nantes deepen Marseille's woes in Ligue 1
Dogs die as South Africa snake antivenom shortage bites
Zarza, a much-loved Staffordshire terrier, ended up at a South African animal hospital with a bite from a Mozambique spitting cobra on her snout.
The snake's powerful venom can stop the breathing muscles from working, but normally the bites are treatable with an antidote.
The problem, say South African veterinarians, is that they currently have virtually no vials of the antiserum left.
"We've been out of antivenom for quite some months now," said Dean de Kock, a vet at the Valley Farm Animal Hospital in Pretoria, where Zarza was treated but eventually died.
Vets and snake experts say the shortage started getting serious towards the end of last year -- though the authorities are denying there is a problem.
"Snakebite antivenom is available in the country," the National Health Laboratory Service (NHLS), a government body in charge of antidote production, told AFP.
Experts in the field disagree.
- A 'countrywide shortage' -
In April, a group of snakebite treatment specialists pleaded with the health minister over what they described as "a major health risk".
While the supply problems may be easing in some quarters, vets say they are still struggling.
Hospitals treating humans get priority when any new doses come available, said Johan Marais, a herpetologist -- specialist in reptiles and amphibians -- who heads the African Snakebite Institute.
"At the moment, if you're a veterinarian, you cannot get antivenom," said Marais, 65.
Speaking from his headquarters in Pretoria, he casually handled a black mamba during his conversation with AFP.
He said he receives up to a dozen calls a day from desperate animal doctors and dog owners looking for antidotes.
"If your dog gets a serious snakebite today, there's a likelihood it's going to die," Marais said.
Alan Kloeck, of the South African Veterinary Association, confirmed Marais's remarks, describing a "countrywide shortage" with vets unable to get their hands on the antiserum they needed.
- Horse blood, spitting cobras -
South Africa is home to about 160 species of snakes, many of them poisonous.
South African Vaccine Producers -- a NHLS subsidiary and the only antivenom maker in the country -- produces two antidotes.
One can treat bites from 10 snakes including the cape cobra, the puff adder and the green mamba, while another is for relatively rare boomslang bites.
Making the antiserums is a laborious process, said Mike Perry of African Reptiles and Venom, a venom-extraction firm in Centurion, outside Johannesburg, that houses around 900 snakes in small glass cages.
He said his team forces the hissing reptiles to spit out their poison by forcing them to bite a glass jar.
Small quantities of the toxins are then injected into horses, which over time develop immunity.
Their plasma is then harvested and processed to make the serum.
But that process requires constant refrigeration, and the production backlog has been blamed in large part on South Africa's energy crisis, which has caused repeated power blackouts.
In April, NHLS said it required "a consistent and dependable power supply" to produce antivenom.
The continuous switchover to generators during outages interrupted production and affected stockpiles, it said, forcing it to invest in backup power systems and renewable energy.
- 'Last vial' -
Last week, NHLS said it had increased manufacturing in recent months.
Since January, it said, it had delivered antivenom to more than 230 institutions, including hospitals and veterinary clinics, fulfilling all orders apart from "a small backlog" affecting a provincial depot.
But de Kock, whose veterinary practice is in a different province, has not received any shipments since December. For a while, they were using expired doses from other hospitals, but these too have dried up.
"We have used the last vial on Sunday evening," he said last week.
Over the past three months, the hospital treated 25 dogs for snakebites.
Of the 16 who could get expired antivenom, only one did not survive, while six of the nine who could not get doses died.
Zarza was among them, dying in May after a two-day struggle on a ventilator.
"It's tough," said de Kock, 53. "You're doing everything you can but the vital thing that you actually need is the antivenom, and you don't have that".
His hope was that the austral winter months, when snakes are less active, would bring some relief.
E.Flores--AT